An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor
eLife · 2023
DOI: 10.7554/elife.88982 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Tim Aguirre und 8 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany. Hauptthemen laut MEDLINE: Phytic Acid, Phosphotransferases (Phosphate Group Acceptor). Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Academic Exchange Service.
Abstract (Originalsprache)
Inositol hexakisphosphate kinases (IP6Ks) are emerging as relevant pharmacological targets because a multitude of disease-related phenotypes has been associated with their function. While the development of potent IP6K inhibitors is gaining momentum, a pharmacological tool to distinguish the mammalian isozymes is still lacking. Here, we implemented an analog-sensitive approach for IP6Ks and performed a high-throughput screen to identify suitable lead compounds. The most promising hit, FMP-201300, exhibited high potency and selectivity toward the unique valine gatekeeper mutants of IP6K1 and IP6K2, compared to the respective wild-type (WT) kinases. Biochemical validation experiments revealed an allosteric mechanism of action that was corroborated by hydrogen deuterium exchange mass spectrometry measurements. The latter analysis suggested that displacement of the α C helix, caused by the gatekeeper mutation, facilitates the binding of FMP-201300 to an allosteric pocket adjacent to the ATP-binding site. FMP-201300 therefore serves as a valuable springboard for the further development of compounds that can selectively target the three mammalian IP6Ks; either as analog-sensitive kinase inhibitors or as an allosteric lead compound for the WT kinases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
- Institut für Chemie, Humboldt-Universität zu Berlin, Berlin, Germany.
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
ORCID-Profile: Tim Aguirre, Sarah Hostachy, Martin Neuenschwander, Volker Haucke, Anja Schütz, Dorothea Fiedler
Förderung
- Deutsche Forschungsgemeinschaft
- German Academic Exchange Service
Zitieren
APA
Aguirre, T., Dornan, G. L., Hostachy, S., Neuenschwander, M., Seyffarth, C., Haucke, V., Schütz, A., von Kries, J. P., & Fiedler, D. (2023). An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor. eLife. https://doi.org/10.7554/elife.88982
Vancouver
Aguirre T, Dornan GL, Hostachy S, Neuenschwander M, Seyffarth C, Haucke V, et al. An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor. eLife. 2023. doi:10.7554/elife.88982
BibTeX
@article{Aguirre2023,
author = {Aguirre, Tim and Dornan, Gillian L and Hostachy, Sarah and Neuenschwander, Martin and Seyffarth, Carola and Haucke, Volker and Schütz, Anja and von Kries, Jens Peter and Fiedler, Dorothea},
title = {An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.88982}
}
EUVIMED